ストックスクリーナーアプリを入手
42.53
4.79%
-2.14
アフターアワーズ：
41.66
-0.87
-2.05%
前日終値:
$44.67
開ける：
$44.21
24時間の取引高:
992.02K
Relative Volume:
0.75
時価総額：
$3.42B
収益：
$541.74M
当期純損益:
$88.01M
株価収益率:
39.15
EPS:
1.0862
ネットキャッシュフロー:
$155.34M
1週間 パフォーマンス:
-1.87%
1か月 パフォーマンス:
-8.36%
6か月 パフォーマンス:
+17.26%
1年 パフォーマンス:
+34.93%
1日の値動き範囲:
$42.43
$44.81
1週間の範囲:
$41.60
$45.99
52週間の値動き範囲:
$29.45
$60.91
Veracyte Inc Stock (VCYT) Company Profile
名前
Veracyte Inc
セクター
電話
(650) 243-6300
住所
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, NTRA, IQV, A
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
42.53 | 3.36B | 541.74M | 88.01M | 155.34M | 1.0862 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Jefferies | Buy |
| 2025-12-02 | 再開されました | Morgan Stanley | Underweight |
| 2025-10-20 | 開始されました | Canaccord Genuity | Hold |
| 2025-03-20 | 開始されました | Craig Hallum | Buy |
| 2024-12-05 | ダウングレード | Goldman | Buy → Neutral |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-10-16 | 開始されました | UBS | Buy |
| 2024-10-10 | 開始されました | Guggenheim | Buy |
| 2024-02-23 | 繰り返されました | Needham | Buy |
| 2023-01-18 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-07 | 開始されました | Stephens | Overweight |
| 2021-11-18 | 再開されました | Goldman | Buy |
| 2021-06-15 | 開始されました | Raymond James | Outperform |
| 2021-02-18 | 再開されました | Needham | Buy |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 開始されました | Morgan Stanley | Underweight |
| 2019-07-31 | 開始されました | Lake Street | Buy |
| 2019-07-02 | 開始されました | Needham | Buy |
| 2018-11-29 | ダウングレード | Janney | Buy → Neutral |
| 2018-10-31 | アップグレード | Janney | Neutral → Buy |
| 2017-11-07 | ダウングレード | Janney | Buy → Neutral |
| 2017-11-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 再開されました | BTIG Research | Buy |
| 2016-11-14 | 再開されました | Leerink Partners | Outperform |
| 2015-12-18 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-06-11 | 繰り返されました | Leerink Partners | Outperform |
| 2013-11-26 | 開始されました | William Blair | Outperform |
すべてを表示
Veracyte Inc (VCYT) 最新ニュース
Virtus Advisers LLC Purchases New Shares in Veracyte, Inc. $VCYT - MarketBeat
Great Lakes Advisors LLC Invests $3.85 Million in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT): Moves 0.50% Down to $41.98 on the Day; Trading Range: the Price Remains Bounded by the Supplied Support and ResistanceDividend Arbitrage - vinanet.vn
Lisanti Capital Growth LLC Purchases Shares of 63,400 Veracyte, Inc. $VCYT - MarketBeat
Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
Summit Creek Advisors LLC Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT) Results at a Glance: EPS Clears the Reported Estimate in Latest Trading; Stock Move: Shares Move Lower 2.50%Investor Earnings Call - vinanet.vn
Rice Hall James & Associates LLC Invests $5.61 Million in Veracyte, Inc. $VCYT - MarketBeat
Veracyte Inc (VCYT) News, Articles, Events & Latest Updates - Stocktwits
Down 30.2% in 4 Weeks, Here's Why Veracyte (VCYT) Looks Ripe for a Turnaround - Yahoo Finance
Is Veracyte (VCYT) Undervalued As Raised 2026 Outlook And Q2 Earnings Lift Interest? - Sahm
Veracyte Inc (VCYT) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
Veracyte Debuts Prosigna Breast Test in the U.S. - Medical Product Outsourcing
Zacks Research Upgrades Veracyte (NASDAQ:VCYT) to Strong-Buy - MarketBeat
Bank of America Corp DE Grows Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (VCYT) Stock Forecasts - Yahoo Finance
A Look at Veracyte Inc (VCYT) After 3.7% Decline -- GF Value $38 - GuruFocus
Amundi Sells 116,588 Shares of Veracyte, Inc. $VCYT - MarketBeat
How Investors May Respond To Veracyte (VCYT) Raising 2026 Revenue Guidance After Returning To Profit - Sahm
Veracyte at canaccord growth conference: growth balanced with margins By Investing.com - Investing.com Canada
Veracyte at canaccord growth conference: growth balanced with margins - Investing.com
Veracyte (VCYT) Dropped, So What Is Behind The Latest Attention? - Sahm
Veracyte: Diagnostics With Favorable Economics (NASDAQ:VCYT) - Seeking Alpha
Veracyte: Core Growth Funds Prosigna And TrueMRD (NASDAQ:VCYT) - Seeking Alpha
Royal Bank of Canada Grows Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. $VCYT Shares Sold by Janus Henderson Group PLC - MarketBeat
CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Cuts Target Price to $50 - Moomoo
Empowered Funds LLC Buys 68,171 Shares of Veracyte, Inc. $VCYT - MarketBeat
Results: Veracyte, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Veracyte (NASDAQ:VCYT) Shows Affordable Growth Potential - ChartMill
Renaissance Technologies LLC Takes Position in Veracyte, Inc. $VCYT - MarketBeat
VERACYTE INC : PIPER SANDLER CUTS TARGET PRICE TO $54.00 FROM $66.00 - Bitget
Medicare Coverage Granted for Veracyte’s Test for Muscle-Invasive Bladder Cancer - Medical Product Outsourcing
Guggenheim Reaffirms Their Buy Rating on Veracyte (VCYT) - The Globe and Mail
Stephens Issues Pessimistic Forecast for Veracyte (NASDAQ:VCYT) Stock Price - MarketBeat
Veracyte (NASDAQ:VCYT) Price Target Cut to $44.00 by Analysts at Morgan Stanley - MarketBeat
Veracyte, Inc. (VCYT): Investor Outlook Reveals a 31.35% Potential Upside Amid Strong Analyst Ratings - DirectorsTalk Interviews
Arrowstreet Capital Limited Partnership Takes Position in Veracyte, Inc. $VCYT - marketbeat.com
Veracyte (VCYT) Is Down 18.2% After Raising 2026 Revenue Guidance on New Cancer Tests - webull.com
Canaccord cuts Veracyte stock price target to $50 on revenue outlook - Investing.com Nigeria
VERACYTE INC : CANACCORD GENUITY CUTS TARGET PRICE TO $50 FROM $60 - Bitget
Veracyte (VCYT) Plunges 22.5%: Critical Support Level in Focus After Steep SelloffDouble Top - Vinanet
VERACYTE, INC. 2026: Revenue $150.32M, EPS $0.31— 10-Q Summary - TradingView
Veracyte | 10-Q: Q2 2026 Earnings Report - Moomoo
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $66 - moomoo.com
Needham raises Veracyte stock price target to $69 on strong Q2 beat - Investing.com Nigeria
Veracyte (NASDAQ:VCYT) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Transcript : Veracyte, Inc., Q2 2026 Earnings Call, Jul 30, 2026 - marketscreener.com
Is Veracyte Inc (VCYT) Still a Strong Investment After Q2 Earnin - GuruFocus
Earnings call transcript: Veracyte beats Q2 2026 estimates but shares fall after hours - Investing.com
Veracyte Q2 Non-GAAP Earnings, Revenue Rise; 2026 Revenue Guidance Raised - Moomoo
Veracyte Inc (VCYT) 財務データ
収益
当期純利益
現金流量
EPS
1.39%
1.15%
大文字化:
|
ボリューム (24 時間):